Literature DB >> 11118071

Functional and structural defects in HIV type 1 nef genes derived from pediatric long-term survivors.

R Geffin1, D Wolf, R Müller, M D Hill, E Stellwag, M Freitag, G Sass, G B Scott, A S Baur.   

Abstract

DNA sequences and three distinct in vitro functions of Nef were evaluated in a group of seven perinatally infected children. nef gene sequences obtained before and after virus culture showed that one of the five non-/slow progressors harbored a virus with large deletions. nef genes from the remaining four children were full length but contained discrete changes at a higher frequency than the rapid progressors. In functional studies, 40 of 44 Nef proteins derived from the whole study group were capable of binding the cellular serine kinase p62, indicating that this function is well conserved among naturally occurring viruses. In contrast, representative Nef proteins derived from the long-term non-/slow progressors were found to be defective or far less capable of enhancing viral replication and/or viral infectivity in herpesvirus saimiri-transformed human T cells and peripheral blood mononuclear cells. On reversion of highly prevalent point mutations in the defective proteins, viral replication could be restored to wild-type levels. Our results suggest that nef genes derived from pediatric long-term nonprogressors have gross deletions in isolated cases but a higher prevalence of discrete changes that may impair Nef function in primary T cell assays, but not all functions reported for Nef.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118071     DOI: 10.1089/08892220050195810

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  19 in total

1.  Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation.

Authors:  Andrea Crotti; Francesca Neri; Davide Corti; Silvia Ghezzi; Silvia Heltai; Andreas Baur; Guido Poli; Elena Santagostino; Elisa Vicenzi
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

2.  Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.

Authors:  Eduardo O'Neill; Lillian S Kuo; John F Krisko; Diana R Tomchick; J Victor Garcia; John L Foster
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Simultaneous assessment of CD4 and MHC-I downregulation by Nef primary isolates in the context of infection.

Authors:  Ayub Ali; Susan Realegeno; Otto O Yang; Martha J Lewis
Journal:  J Virol Methods       Date:  2009-07-28       Impact factor: 2.014

4.  Vertically transmitted HIV infection having first clinical manifestations at 13 y of age.

Authors:  Amitabh Sagar; Biju Vasudevan
Journal:  Indian J Pediatr       Date:  2011-12-29       Impact factor: 1.967

5.  Functional analysis of HIV type 1 Nef gene variants from adolescent and adult survivors of perinatal infection.

Authors:  Jun Zuo; Jeffrey Suen; Alanna Wong; Martha Lewis; Ali Ayub; Marvin Belzer; Joseph Church; Otto O Yang; Paul Krogstad
Journal:  AIDS Res Hum Retroviruses       Date:  2011-10-03       Impact factor: 2.205

6.  Comparative genetic variability in HIV-1 subtype C p24 Gene in early age groups of infants.

Authors:  Uma Sharma; Sunil Gupta; S Venkatesh; Arvind Rai; A C Dhariwal; Mohammad Husain
Journal:  Virus Genes       Date:  2018-07-18       Impact factor: 2.332

7.  Ineffectual targeting of HIV-1 Nef by cytotoxic T lymphocytes in acute infection results in no functional impairment or viremia reduction.

Authors:  Justin De La Cruz; Thomas Vollbrecht; Patricia Frohnen; Hwee L Ng; Eric S Daar; Otto O Yang; Martha J Lewis
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

8.  CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 nef protein in pediatric AIDS progression.

Authors:  Nicoletta Casartelli; Gigliola Di Matteo; Marina Potestà; Paolo Rossi; Margherita Doria
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Meta-analysis to test the association of HIV-1 nef amino acid differences and deletions with disease progression.

Authors:  Ravindra Pushker; Jean-Marc Jacqué; Denis C Shields
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

10.  Predicting the impact of blocking human immunodeficiency virus type 1 Nef in vivo.

Authors:  W David Wick; Peter B Gilbert; Otto O Yang
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.